* Nemaura Medical Inc NMRD.OQ reported a quarterly
adjusted loss
of 15 cents per share for the quarter ended in December. The
mean expectation of two analysts for the quarter was for a loss
of 14 cents per share.
* Revenue was $184.00 thousand; analysts expected $150.00
thousand.
* Nemaura Medical Inc's reported EPS for the quarter was a
loss
of 15 cents.
* The mean earnings estimate of analysts had fallen by
about 27.3%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Nemaura Medical Inc shares had fallen by 7.9% this
quarter.
* The company reported a quarterly loss of $3.43 million.
* Wall Street's median 12-month price target for Nemaura
Medical
Inc is $13.25
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated February 14 at 10:02 p.m.
All figures in US dollars unless otherwise stated